Acting Attorney General Todd Blanche privately assured a group of anti-abortion activists this week that the Justice Department is working to ensure the Supreme Court’s Dobbs decision becomes a lasting, nationwide reality — a pledge that thrilled pro-life advocates who’ve grown impatient with the pace of federal action since Roe v. Wade was overturned, even as it drew immediate pushback from Democrats and some abortion-rights groups.
What Blanche Told the Group
Blanche made the comments on a call hosted by the White House Faith Office with Intercessors for America, a Christian advocacy organization, in a recording the group later posted publicly. “We’re working, hand in hand with HHS and the FDA and the White House and President Trump’s team, to get permanent solutions, so that the Dobbs decision becomes permanent in every single state,” Blanche told the group. He went on to project confidence about the ultimate outcome: “We don’t have complete victory yet, but we will have victory, and victory will be soon, and it will be permanent.”
Blanche also signaled that the administration is preparing new restrictions on the prescription and mail delivery of abortion pills such as mifepristone, specifically targeting states that have adopted “shield laws” allowing doctors to prescribe abortion medication to patients living in other states. That approach isn’t new — Blanche had already committed to addressing mail-order abortion pill access during his own confirmation hearing, after being pressed on the issue by Sen. Katie Britt, R-Ala.
A Win Pro-Life Advocates Have Been Waiting For
For supporters of the pro-life movement, Blanche’s comments represent exactly the kind of sustained federal commitment they’d hoped to see following the Dobbs ruling, and confirmation that the administration intends to use the tools available to the Justice Department — not just leave the matter entirely to individual states — to protect unborn life nationwide. Advocates have grown frustrated in recent years watching abortion pill access expand dramatically through telehealth and mail-order prescriptions, which now account for the majority of abortions performed in the country; a DOJ-led effort to close that avenue, working alongside HHS and the FDA, is precisely the kind of coordinated executive action many pro-life leaders have been pushing for since Roe fell.
Democrats and Some Republicans Push Back
The comments landed differently on the other side of the aisle. Sen. Patty Murray, D-Wash., seized on the remarks ahead of Blanche’s Senate confirmation vote, telling colleagues that a vote for Blanche was effectively a vote for an attorney general who would “attack abortion rights in every state” — repeating Blanche’s own “every single state” language back at him. Sen. Tina Smith, D-Minn., made a similar argument, saying the private call revealed Blanche’s true intentions more clearly than his public confirmation testimony had.
Notably, the pushback wasn’t confined entirely to Democrats. Sen. Susan Collins, R-Maine, a longtime supporter of abortion rights within the GOP conference, announced she would oppose Blanche’s nomination, citing both his private assurances to anti-abortion groups and a separate controversy over an IRS audit shield for the Trump family. Collins’ defection illustrates that Blanche’s posture on abortion pushes further than some in his own party are comfortable going, even within a Republican-controlled Senate broadly supportive of his nomination.
The Larger Legal Strategy
Reporting on the episode suggests the administration’s approach centers heavily on regulatory and legal action rather than legislation — a strategy that avoids the difficulty of passing a nationwide abortion law through a closely divided Congress. Anti-abortion groups have spent months pushing to resolve Louisiana v. FDA, a case that could restrict the mail-order mifepristone system through the courts rather than through a congressional vote. Supporters argue this is simply smart, available use of existing federal authority; critics argue it’s an attempt to achieve through executive and regulatory action what couldn’t be achieved through the ordinary legislative process — though of course, that critique cuts both ways depending on which policy area and which administration one is examining.
Where Things Stand
Blanche’s confirmation vote in the full Senate is expected soon after clearing the Judiciary Committee earlier this week by a 12-10 vote. Given the Republican majority in the chamber, he is likely to be confirmed even with Collins’ opposition, positioning him to begin implementing the policy priorities he outlined to Intercessors for America almost immediately upon taking the job on a permanent basis. Advocates on both sides of the abortion debate are likely to be watching closely for the administration’s next moves on mifepristone access and the shield-law states in the weeks following his confirmation.
This story is developing.
